Literature DB >> 11380319

Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis.

T Koike1, S Ohara, H Sekine, K Iijima, K Kato, T Toyota, T Shimosegawa.   

Abstract

BACKGROUND: The role of acid secretion in reflux oesophagitis which may develop after H. pylori eradication is not well known. AIM: To investigate the participation of altered gastric acid secretion and the presence of hiatal hernia in the development of reflux oesophagitis after eradication therapy for H. pylori. SUBJECTS AND METHODS: A total of 105 patients with H. pylori infection, but without reflux oesophagitis at the time of eradication therapy, were followed prospectively for 7 months after the clearance of this microorganism. Gastric acid secretion was assessed by endoscopic gastrin test, and the presence of hiatal hernia by endoscopy.
RESULTS: Reflux oesophagitis developed in 11 out of 105 (10.5%) patients when examined at 7 months after the eradication therapy. The incidence was correlated significantly with the increase in gastric acid secretion after the eradication of H. pylori, and was significantly higher in the patients with hiatal hernia (20%) than in those without it (0%).
CONCLUSIONS: Increased acid secretion after H. pylori eradication is an important risk factor of reflux oesophagitis, especially in patients with hiatal hernia.

Entities:  

Mesh:

Year:  2001        PMID: 11380319     DOI: 10.1046/j.1365-2036.2001.00988.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  22 in total

1.  Helicobacter pylori infection and long term proton pump inhibitor therapy.

Authors:  K E L McColl
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

Review 2.  Helicobacter pylori and oesophageal cancer--not always protective.

Authors:  Kenneth E L McColl
Journal:  Gut       Date:  2007-04       Impact factor: 23.059

Review 3.  The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.

Authors:  P Malfertheiner; U Peitz
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

4.  The effect of intragastric ammonia production on titratable gastric acid output in Helicobacter pylori-infected patients with chronic gastritis.

Authors:  Bogdan Cylwik; Jan W Dlugosz; Andrzej Kemona; Maciej Szmitkowski
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

Review 5.  Does Helicobacter pylori infection protect against esophageal diseases in Asia?

Authors:  Justin C Y Wu
Journal:  Indian J Gastroenterol       Date:  2011-08-26

6.  Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.

Authors:  E J Kuipers; G F Nelis; E C Klinkenberg-Knol; P Snel; D Goldfain; J J Kolkman; H P M Festen; J Dent; P Zeitoun; N Havu; M Lamm; A Walan
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

7.  Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication.

Authors:  Katsunori Iijima; Tomoyuki Koike; Yasuhiko Abe; Nobuyuki Ara; Kaname Uno; Akira Imatani; Shuichi Ohara; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2009-05-14       Impact factor: 7.527

Review 8.  Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.

Authors:  Antonio Galvao Neto; April Whitaker; Zhiheng Pei
Journal:  Semin Oncol       Date:  2015-09-07       Impact factor: 4.929

9.  Relationship of gastric Helicobacter pylori infection to Barrett's esophagus and gastro-esophageal reflux disease in Chinese.

Authors:  Jun Zhang; Xiao-Li Chen; Kang-Min Wang; Xiao-Dan Guo; Ai-Li Zuo; Jun Gong
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

10.  Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project.

Authors:  Richard F Harvey; J Athene Lane; Liam J Murray; Ian M Harvey; Jenny L Donovan; Prakash Nair
Journal:  BMJ       Date:  2004-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.